Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | Director | May 04, 2026 | May 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
WEST PHARMACEUTICAL SERVICES INC
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,560.479 |
Reported balance
After 2026-05-04 transaction · row 1
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 791 · Balance 11,560.479 F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2026 Filed May 6, 2026 21:30 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000062 · form4.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,560.479 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:32 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013700 · form4.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,656.72 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 20:39 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013404 · form4.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,585.72 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:11 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-003694 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,021.72 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of the grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
| May 24, 2022 Filed May 26, 2022 19:48 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004426 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,405.72 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
| May 04, 2021 Filed May 6, 2021 23:27 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-003306 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,773.72 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| May 05, 2020 Filed May 7, 2020 22:09 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-003470 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,180.3407 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| May 07, 2019 Filed May 9, 2019 19:10 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-19-002727 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,880.7466 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:13 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 204 | $98.03 | $19,998.12 |
DisclosureSEC source: 0001562180-19-000128 · primarydocument.xml · derivative · entry 2 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278.8707 Underlying: Common Stock · 204 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 17:17 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 162 | $123.74 | $20,045.88 |
DisclosureSEC source: 0001562180-18-004089 · primarydocument.xml · derivative · entry 2 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072.2514 Underlying: Common Stock · 162 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| June 29, 2018 Filed Aug 1, 2018 20:35 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 202.1445 | $99.29 | $20,070.93 |
DisclosureSEC source: 0001562180-18-003446 · primarydocument.xml · derivative · entry 4 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910.2514 Underlying: Common Stock · 202.1445 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| May 01, 2018 Filed May 3, 2018 21:46 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-002197 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,309.2132 F1 · price: These shares of restricted stock units will vest in full on the first anniversay of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| March 29, 2018 Filed Aug 1, 2018 20:35 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 227.6707 | $86.72 | $19,743.60 |
DisclosureSEC source: 0001562180-18-003446 · primarydocument.xml · derivative · entry 3 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708.1069 Underlying: Common Stock · 227.6707 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| December 29, 2017 Filed Aug 1, 2018 20:35 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 202.0787 | $99.16 | $20,038.12 |
DisclosureSEC source: 0001562180-18-003446 · primarydocument.xml · derivative · entry 2 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480.4362 Underlying: Common Stock · 202.0787 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 19:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 207.6196 | $96.33 | $20,000.00 |
DisclosureSEC source: 0001562180-17-003160 · primarydocument.xml · derivative · entry 2 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278.3575 Underlying: Common Stock · 207.6196 shares Expires not disclosed F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:39 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantPhantom Stock Unit · Derivative | 70.6325 | $94.39 | $6,667.00 |
DisclosureSEC source: 0001562180-17-002376 · primarydocument.xml · derivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70.6325 Underlying: Common Stock · 70.6325 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 10:03 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-002114 · primarydocument.xml · nonDerivative · entry 1 Keller Deborah L · CIK 0001352992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483 F1 · price: These shares of restricted stock units will vest in full after 11 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.